The medication is a triple-agonist drug, meaning it mimics three appetite hormones: GLP-1, GIP, and glucagon
Imaging includes X-rays, sonography, ultrasound (US) magnetic resonance imaging (MRI), and computed tomography (CT)
Durand P, Lussier-Cacan S, and Blache D (1997a)
Frequent glucose spikes contribute to insulin resistance, while keeping blood sugar more stable makes you more insulin sensitive
BPC-157 is primarily a research compound Evidence quality : Both lack large human clinical trials, but GHK-Cu has more human data for skin applications Conclusion# BPC-157 and GHK-Cu serve complementary rather than competing roles in tissue healing research
For many people, this combination may result in losing 1020% of their body weight over a year, depending on their adherence to the treatment plan and lifestyle changes